The survival rates of large, medium, and small RGCs was evaluated for different EPO’s dose by retinal flat mount analysis: The survival rates of RGCs were determined as groups (1) Control, (2) NMDA-mediated (80 nmoles NMDA), and (3–5) EPO-treated groups (80 nmoles NMDA + 10, 50, 250 ng EPO).
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
The survival rates of large, medium, and small RGCs was evaluated for different EPO’s dose by retinal flat mount analysis: The survival rates of RGCs were determined as groups (1) Control, (2) NMDA-mediated (80 nmoles NMDA), and (3–5) EPO-treated groups (80 nmoles NMDA + 10, 50, 250 ng EPO).
创建时间：
2020-04-17
